Icon

LASIX (nda016273)- (20MG,40MG,80MG)

FUROSEMIDE VALIDUS PHARMS
20MG,40MG,80MG
No No
Expired Expired
None None
None No
LASIX is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Oral LASIX may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.
6 0 6
Total Other Developers 7
Drugs with Suitability No
20MG ** ** - - 3
40MG ** ** - - 3
80MG ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ******, *** *********** * *** **, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ******* ******, *** *********** * *** **, *********, *** ****** (**) *****, ****** ****** (***) ***
****** **** **** *** **** ************ ******* *********** **** **. **, ** *** ***, ******** ********** ******, *******, ********, *.*. ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** **** **** *** ******** **** *******, ***. *********** * ******* *****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ****** ******* *************** ******* ******* *********** ****** **. ***/* & ***/**, ******* *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ***** *************** ***. *********** **** ******* ***** ****, **********, **** ******** (**) *****, ****** ****** (***) ***
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ***** *** ******* *************** ******* *** *********** ****** ** ***/*/**, *** ******** (*), ******** (*),, ********** (****),, ********* *** ***, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.